Literature DB >> 21674579

Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN.

Nils H Thoennissen1, Terra Lasho, Gabriela B Thoennissen, Seishi Ogawa, Ayalew Tefferi, H Phillip Koeffler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21674579     DOI： 10.1002/ajh.22069

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  11 in total

1.  One thousand patients with primary myelofibrosis: the mayo clinic experience.

Authors:  Ayalew Tefferi; Terra L Lasho; Thitina Jimma; Christy M Finke; Naseema Gangat; Rakhee Vaidya; Kebede H Begna; Aref Al-Kali; Rhett P Ketterling; Curtis A Hanson; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

2.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

3.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

Review 4.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

5.  Recurrent genetic defects on chromosome 7q in myeloid neoplasms.

Authors:  N Hosono; H Makishima; A Jerez; K Yoshida; B Przychodzen; S McMahon; Y Shiraishi; K Chiba; H Tanaka; S Miyano; M Sanada; I Gómez-Seguí; A K Verma; M A McDevitt; M A Sekeres; S Ogawa; J P Maciejewski
Journal:  Leukemia       Date:  2014-01-16       Impact factor: 11.528

6.  Distinct clinical and biological implications of CUX1 in myeloid neoplasms.

Authors:  Mai Aly; Zubaidah M Ramdzan; Yasunobu Nagata; Suresh K Balasubramanian; Naoko Hosono; Hideki Makishima; Valeria Visconte; Teodora Kuzmanovic; Vera Adema; Aziz Nazha; Bartlomiej P Przychodzen; Cassandra M Kerr; Mikkael A Sekeres; Mohamed E Abazeed; Alain Nepveu; Jaroslaw P Maciejewski
Journal:  Blood Adv       Date:  2019-07-23

7.  CUX2 functions as an oncogene in papillary thyroid cancer.

Authors:  Yihan Sun; Danrong Ye; Yuefeng Li; Endong Chen; Rutian Hao; Yefeng Cai; Qingxuan Wang; Ouchen Wang; Xiaohua Zhang
Journal:  Onco Targets Ther       Date:  2018-12-24       Impact factor: 4.147

Review 8.  Genetic basis of myelodysplastic syndromes.

Authors:  Seishi Ogawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

Review 9.  Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Authors:  Ilaria Iacobucci; Annalisa Lonetti; Cristina Papayannidis; Giovanni Martinelli
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

Review 10.  CUX1, A Controversial Player in Tumor Development.

Authors:  Ning Liu; Qiliang Sun; Long Wan; Xuan Wang; Yu Feng; Judong Luo; Hailong Wu
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.